跳至主要内容
临床试验/NCT04144725
NCT04144725进行中(未招募)不适用

Ruling Out Coronary Artery Disease and Myocardial Injury by BiOmarkers: Light'n Easy

University Hospital, Akershus2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2019年10月23日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,000
试验地点
2
主要终点
The presence of obstructive coronary artery stenosis defined as diameter > 50% on CCTA

研究概览

简要总结

A considerable proportion of patients with clinically suspected coronary artery disease (CAD) do not have angiographic signs of luminal narrowing caused by coronary atherosclerosis. In patients with suspected CAD, we will assess the ability of cardiovascular biomarkers to identify patients with (a) angiographically normal epicardial coronary vessels (b) absence of significant epicardial coronary stenosis, as assessed by coronary computed tomography angiography (CCTA). Patients will be stratified according to the presence or absence of dynamic changes of high sensitivity cardiac troponin T levels above the 99th percentile.

详细描述

This is an observational study of patients with suspected coronary artery disease referred to coronary computed tomography angiography (CCTA). The plan is to include 1000 patients prior to CCTA at two centers.

Blood samples for biomarker measurement will be obtained prior to the procedures. The diagnostic results of the imaging tests will be compared to the levels of circulating troponins. Patient will be followed for a minimum of 12 months and the incidence of cardiovascular death, all-cause mortality, acute coronary syndromes, revascularization, heart failure, stroke and cardiac arrhythmias requiring rehospitalization. Symptoms of angina pectoris according to the Canadian Cardiovascular Society grading of angina pectoris and symptoms of chronic heart failure according to the New York Heart Association classification of chronic heart failure will be recorded.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consenting patient over the age of 18 referred to CCTA for suspected coronary artery disease

排除标准

  • Inability to provide informed consent.
  • Short life expectancy (<12 months) due to non-cardiovascular disease

结局指标

主要结局

The presence of obstructive coronary artery stenosis defined as diameter > 50% on CCTA

时间窗: 0 days (Cross-sectional)

Diagnostic end-point

次要结局

  • The presence of non-obstructive coronary artery stenosis defined as diameter stenosis 30-50% on CCTA(0 days (Cross-sectional))
  • Composite of cardiovascular death and hospitalization for heart failure or acute coronary syndrome(Follow-up until 2030)
  • Incidence of cardiovascular death, hospitalization for myocardial infarction, unstable angina, revascularization, stroke, heart failure and cardiac arrhythmias.(Follow-up until 2030)

研究者

发起方
University Hospital, Akershus
申办方类型
Other
责任方
Principal Investigator
主要研究者

Torbjorn Omland

Professor

University Hospital, Akershus

研究点 (2)

Loading locations...

相似试验